CES is a clinical picture of perineal sensory loss with loss of voluntary control of both anal and urethral sphincter and of sexual responsiveness. Clinical signs accompanying CES may differ in each patient, but the fully developed syndrome is characterized by lowback pain, bilateral sciatica, saddle hypoesthesia or anesthesia, motor weakness of lower extremities, impairment of anal, bulbocavernous, medioplantar and Achilles tendon reflexes bilaterally, rectal and bladder sphincter dysfunction, as well as sexual impotence. CES is not only secondary to disc disease, but also to other spinal canal pathologies as well. The etiologies can be grouped as non-neoplastic compressive
Introduction
Multiple myeloma (MM) is a hematological malignancy that is characterized by presence of proliferation of clonal plasma cells which are producing a monoclonal immunoglobulin [1] . Nervous system involvement is an important complication. Cauda equina syndrome (CES) is defined as the constellation of symptoms that includes lowback pain, sciatica, saddle anesthesia, decreased rectal tone and perineal reflexes, bowel and bladder dysfunction, and variable amounts of lower-extremity weakness [2] . There are several causes of this syndrome including trauma, central disc protrusion, hemorrhage, and neoplastic invasion. We presented a case who newly diagnosed MM which complicated with cauda equina involvement.
Case report
Written informed consent was obtained from the patient.
51-year-old women admitted to our hospital because of weakness and low back pain. Physical examination revealed pallor and low back pain. Neurological examination demonstrated urinary and anal sphincter dysfunction, decreased rectal tone and perineal reflexes, saddle anesthesia, decreased bilateral Achilles tendon reflexes, frust paraparesia, reflected cauda equina syndrome.
Laboratory analysis were anemia (Hb: 9 gr/dL, Hct: 27 %), elevated erythrocyte sedimentation rate (68 mm/h) and hipergammaglobulinemia (globulin 3.7 g/dL). Serum creatinine (1.75 mg/dL), serum calcium (10.9 mg/dL), β2-microglobulin (3452 ng/ ml) and C reactive protein (5.1 mg/dL) levels are elevated. Serum protein electrophoresis demonstrated monoclonal peak. Serum immunoglobulin G (IgG) and kappa light chain levels were 2282 mg/ dL and 1014 mg/dL, respectively.
Skeletal survey showed multiple lytic lesions and vertebral compression fractures. Bone marrow aspiration smears and trephine biopsy were demonstrated infiltration of atypical plasma cells, reflecting myeloma. The patient diagnosed stage III A IgG-kappa myeloma. Magnetic resonance imaging (MRI) of the spine showed multiple vertebral compression fractures, marked contrast enhancement of lumbar meningeal region and two solid mass of L4-L5 and L5-S1 segment localization (Figure 1 ). Standard dose of VAD regimen was administered as vincristine 0.4 mg/day D1-4, doxorubicin 9 mg/m2/day D1-4 and dexamethasone 25 mg/m2/day D1-4 and every three weeks interval bisphosphonate treatment was applied. After 2 cycles of VAD treatment, MRI showed disappearance of infiltration and neurologic findings were regressed ( Figure 2 ). MM is a plasma cell disorder that both bone (pathologic fractures, spinal cord compression) and neurologic complications (spinal cord and nerve root compression) are seen in progress of myeloma [4] . But cauda equina involvement is a rare complication.
In the literature, there are some case reports that MM complicated with cauda equina syndrome [5] [6] [7] [8] . In a report, a case with MM and sacral insufficiency fracture complicated by epidural hematoma and partial cauda equina compression was presented. In this paper, patient with myeloma in plateau phase had been presented with a short history (less than 12 h) of low back pain, parasthesia and lower limb weakness. She had diagnosed sacral insufficiency fracture complicated by epidural hematoma and partial cauda equina compression [5] . In other paper, a case who presenting with cauda equina and cerebrum involvement in myeloma patient after hematologic complete remission had been reported [6] . Another report was described a case who diagnosed cauda equina relapse after autologous stem cell transplantation in a patient with primary plasma cell leukemia [7] . Quint et al. reported a case with MM who had presented with a 1-week history of progressive bilateral lower extremity pain and weakness [8] . Our patient was presented with CES and diagnosed MM with cauda equina involvement.
MRI should be the best initial procedure for patients with suspected CES [2] . Bell et al. recommend emergency MRI be assessed in all patients who present with new onset of urinary symptoms in the context of lumbar back pain or sciatica in order to avoid misdiagnosis or missed diagnosis of CES [9] .
A diagnosis of myeloma and CES related to cauda equina involvement of myeloma was made at the same time in our patient. MRI was performed for diagnosis of CES. After chemotherapy for myeloma treatment, all symptoms and radiological findings were disappeared. This rare complication should be remembered in patients with MM who presented low back pain and other neurological symptoms of CES.
